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Susceptibility to experimental allergic encephalomyelitis (EAE)
was investigated in DA -rets of both sexes, aged 5, 8 or 27 weeks.
Guinea pig or Lewis rat spinal cords (GPSC or RSC) emulsified in
complete Freund's adjuvant were used for both induction and
reinduction of EAE. The results showed that: a) sex has no influence
on clinical signs of EAE in young DA rats aged 5 or 8 weeks; b)
susceptibility to EAE induction increases with age; c) RSC is a more
potent encephalitogen than GPSC;d) GPSCis a more effective antigen
for anti-MBP antibody production than RSC; e) anti-MBP antibody
levels are not correlated with clinical score of EAE; f) EAE can be
reinduced in 27-week- old rats if RSC is used for induction and/or
reinduction; and g) anti-MBP antibodies are not related to resistance
to EAE reinduction in DA rats.
Key words: experimental allergic encephalomyelitis, DA rats,
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INTRODUCTION
Experimental allergic encephalomyelitis (EAE) is a T cell-mediated
inflammatory demyelinating disorder of the central nervous system (CNS) which
serves as an animal model for the human disease multiple sclerosis (MS)
(Swanborg, 1995). The disease is characterized by opening of the blood-brain
barrier, perivascular infiltration of lymphocytes into the CNS, local inflammation
and demyelination in the form of plaques. EAE is accompanied by the presence
of serum autoantibodies against nervous tissue antigens, particularly myelin basic
protein (MBP). The significance of these autoantibodies is not yet understood
since both pathological and protective effects have been described (reviewed in
Paterson and Halberg, 1980). Neurological symptoms consist of pareses and
paralyses, which first affect the tail, and then progress to hindlimbs and forelimbs.
Spontaneous recovery from the disease, that appears several days later, is
associated with an increase in endogenous corticosteroid serum levels, indicating
neuroendocrine regulation of EAE (MacPhee and Mason, 1990). A second rnilder
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attack of the disease may develop 5-10 days following recovery, and thereafter
the animals are refractory to reinduction of EAE.
Marked differences in susceptibility to EAE among strains originate from
genetic variations in the expression of major histocompatibility products (Fritz et
al., 1983: Williams and Moore, 1973) and differential cytokine production after
challenge with the encephalitogen (Vukmanovic et et., 1989). The susceptibility of
Lewis rats was ascribed to deficient secretion of corticotrophin-releasing hormone
in the hypothalamus in response to inflammation (Sternberg, 1995).
EAE can be induced by immunization with spinal cord homogenate, myelin
basic protein (MBP), proteolipid protein (PLP), myelin oligodendrocyte
Diycoprotein (MOG), or encephalitogenic peptides from these myelin
components. The form of EAE, acute, chronic or relapsing, in the susceptible
strains partly depends on the antigen and adjuvant utilized for immunization. For
instance, MBP and PLP induce relapsing EAE in the H-2b strain of mice, while
MOG peptide 35-55 causes chronic neurological impairment without relapses
(Mendel et a!', 1995). In Lewis and DA rat strains immunization with MBP or spinal
cord homogenate in complete Freundzs adjuvant (CFA) induces acute EAE.
However, it was demonstrated that DA rats develop severe, protracted and
relapsing EAE (SPR-·EAE) after immunization with syngeneic spinal cord and
incomplete Freundzs adjuvant (Lorentzen et al., 1995). The induction of SPR-EAE
'Nas associated with humoral autoreactivity to MOG and cellular auto reactivity to
rat MBP peptides 69-87 and 8'7-·101.
Most of the studies on EAE in rats were performed in the Lewis strain.
However, during the last decade several laboratories have demonstrated that DA
rats were equally or even more susceptible to the induction of autoimmune
diseases in comparison with Lewis rats. The aim of the present study was to
investigate the effect of age and encephalitogen on the induction and reinduction
of EAE in DA rats. Secondly, the possible correlation between anti-MBP antibodies
and the severity of the clinical disease was tested.
MATERIAL AND METHODS
Animals: Inbred Dark Agouti (DA) rats from a breeding colony at the
Immunology Research Center "Branislav Jankovic" were used. Sex- and age-
matched animals were housed 3-4 per cage and given a standard diet and tap
water ad libitum.
Induction and reinduetion of EAE: EAE was induced in male and female DA
rats aged 5 and 8 weeks and in male rats at the age of 27 weeks. Rats were
immunized by intradermal injection in the hind footpad of 0.1 ml of an emulsion
containing guinea pig spinal cord (GPSC) homogenate or Lewis rat spinal cord
(RSC) homogenate (20 mq/rat) in an equal volume of complete Freundzs adjuvant
(CFA; 0.3 mg Mycobacterium tUberculosis/rat). In addition, rats received ~
subcutaneous injection of 0.3 ml Bordetella pertussis vaccine (9 x 10
organisms/rat) in the dorsum ofthe same foot. Reinduction of EAE was performed
3 weeks after induction of EAE or injection of CFA only. Animals were scored daily
for clinical signs of the disease on a scale from 0 to 4 defined as follows: 0, no
clinical signs; 1, flaccid tail; 2, weakness of hind limbs; 3, paralysis of hind limbs;
and 4, quadriplegia and moribund state.
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Determination of anti-MBP antibodies: Blood samples were obtained by
cardiac puncture under aether anesthesia 20 days after induction and 14 days
after reinduction of EAE. Serum levels of antibodies to rat MBP were determined
by ELISA as previously described (Djordjevic et aI., 1992). Briefly, plates were
coated with 1 fl9/ml of rat MBP (kindly provided by Dr. George Hashim, St.
Luke-Roosevelt Hospital, New York) and saturated with 1% bovine serum albumin
solution. Individual serum samples, 1/100 dilution, were tested in triplicate.
Peroxidase-conjugated anti-rat IgG in the dilution 1/6000 was used as a secondary
antibody. Optical densities were measured in a flow multiscan photometer at 492
nm.
Data analysis: All biometric calculations were performed using the statistical
package STAT VIEW II. All data were analyzed using three-factorial analyses of
variance (ANOVA) with age, sex and encephalitogen as factors, and reanalyzed
by means of single factor ANOVA.The Fisher protected least-significant difference
test was used for post hoc comparisons between groups. Data are presented as
means ± standard errors (S.E.)
RESULTS
Clinical EAE in DA rats immunized with GPSC or RSC at different ages is
presented in Table 1. Since there were no statistically significant differences
between the parameters of the disease in male and female DA rats 5 and 8 weeks
old, their data were pooled. The results showed that 5-week old DA rats me less
Table 1: Induction of EAE in DA rats 5, 8 or 27 weeks old
ClinicalEncepha- Incidence Day of
Age litogen (%) onset score
__._.~ ._.__.._._.. __ ~ ..._. . J)(_~:~L .... _..__.{~.~!=J
5-week-old GPSCI2/24 (50) 8.8 etO.5 0.9 ±O.1*




















*Statistically significant differences \IS. all other groups, p < 0.01; and "Statistically significant
differences vs. 27-week-old rats immunized with GPSC homogenate, p < 0.05.
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susceptible to EAE in comparison with 8- and 27-week old rats (lower incidence,
less severe clinical signs and shorter duration of clinical disease). There were no
differences in the severity of EAE between 8- and 27-week old rats. In both 5- and
8-week old rats the disease appeared earlier in the RSC immunized group when
compared with GPSC immunized rats. Furthermore, in 27-week-old DA rats EAE
was more pronounced in the RSC group as revealed by the clinical score and
duration of the disease.
Reinduction of EAE in DA rats aged 5 and 8 weeks was performed with the
same antigen that was used for the induction of the disease. However, none of
the rats developed clinical disease. Rats preimmunized with CFA were completely
resistant to EAE after injection of encephalitogen. Conversely, 27-week old rats
were susceptible to EAE reinduction only when RSC was used for induction and/or
reinduction of the disease Crable2). The incidence and the severity of clinical signs
were lower in this second episode of the disease in comparison with acute EAE.
Table 2: Reinduction of EAE in DA rats at the age of 27 weeks
___________, __0_"____
Encephalitogen for Day of Clinical Duration
induction/reinduction Incidence onset score in days
(%) (x ±SE) (x ±SE) (x ±SEL
GPSC/ GPSC 0/8 (0)
RSC/ GPSC 3/7 (43) 6.0 ± 0.6 1.3 ± 0.4 3.3 ± 0.2
CFN GPSC 0/5 (0)
GPSC/ RSC 3;9 (33) 7.0 ± 0.3 0.8 ± 0.4 3.0 ± 0.6
RSC/ RSC 3/7 (43) 7.7 ~± 0.6 1.0 ± 0.4 2.7 ± 0.6
CFN RSC 0/5 (0)
The level of anti-MBP antibodies was lower in rats immunized with GPSC or
RSC for the induction of EAE at age of 5 weeks in comparison with 8-week old
rats (Figure 1). After reinduction of EAE there were no differences in the anti-MBP
antibody levels between 5- and 8-week old rats. In both age groups, higher
anti-MBP antibody secretion was observed in GPSC immunized animals. The level
of anti-MBP antibodies was decreased in the CFA/GPSC and CFA/RSC groups in
comparison with GPSC/GPSC, but this was not statistically significant in
comparison with the RSC/RSC group.
Similarly to 5- and 8-week-old DA rats, increased anti-MBP antibody levels
were observed in 27-week-old rats after induction of EAE with GPSC compared
to the RSC group (Figure 2). As for the reinduction of EAE, higher anti-MBP
antibody levels were found in the GPSC/GPSC, GPSC/RSC and RSC/GPSC
groups in comparison with the RSC/RSC, CFA/GPSC and CFA/RSC groups.
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Figure 1. Figure 1: Anti-MBP antibodies in sera of 5- and 8-week-old DA rats after induction and
reinduction of EAE with GPSC or RSC homogenate in CFA. Statistically significant
differences: 'k GPSC vs. RSC and CFA, and GPSC/GPSC vs. RSC/RSC, CFA/GPSC and
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Figure 2. Figure 2: Anti-MBP antibodies in sera of 27-week old DA rats after Induction and reinduction
of EAE with GPSC or RSC homogenate in CFA. Statistically significant differences: * GPSC
vs. RSC, P0.001; and a GPSC/GPSC, GPSC/RSC and RSC/GPSC VS. RSC/RSC, CFA/GPSC
and CFA/RSC, p<0.01.
DISCUSSION
The results of the present experiments showed that susceptibility to EAE
induction in DA rats increased with age. The high susceptibility to EAE of DA rats
aged 8 or 27 weeks is in accordance with the reported sensitivity of this rat strain
to autoimmune inflammatory diseases, particularly those mediated by CD4+
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lymphocytes (Lorentzen etal., 1995a,b). The sensitivity of DA rats to EAE induction
was related to both MHC and non-MHC gene products (Lorentzen et al., 1997)
and to the profound secretion of proinflammatory cytokines in response to the
encephalitogen (Vukmanovi6 et el., 1989; Diab et et., 1997). In contrast, we have
found that 5-week-old DA rats were relatively resistant to EAE induction, as
revealed by lower incidence and less severe clinical signs in comparison with 8
weeks old rats. Since the adrenocortical system hass fully developed by the age
of Bweeks, it can be speculated that the difference in hypothalamo-pituitary axes
(t'IPA) activity between 5- and 8-week-old rats is responsible for the observed
distinction in the incidence of EAE (Sapolski and Meaney, 1986). In addition, the
age related susceptibility to the development of EAE in rats is in agreement with
the age-related sensitivity to MS.
The finding that RSC homogenate is a more potent encephalitogen than
GPSC homogenate for the induction of EAE in DA rats indicated that more than
one clone of CD4+ T lymphocytes is involved in the disease. These cell clones
may recognize different epitopes on MBP origining from rat or guinea pig spinal
cord, or epitopes on other nervous tissue proteins, such as MOG. An investigation
of T cell epitopes of guinea pig MBP that induce EAE in DA rats, using synthetic
peptides that correspond to regions of the guinea pig MBP molecule that are
homologous to rat MBP, disclosed four peptides encephalitogenic when tested
in DA rats (Stepaniak et a/., 1997). T cells from DA rats immunized with intact MBP
proliferated in response to the whole protein and to MBP79-99, but were not
stimulated to a significant extent by the other encephalitogenic peptides,
suggesting that these may represent cryptic or subdominant epitopes. Our finding
that EAE can be reinduced in DA rats at the age of 27 weeks only if RSC was used
either for induction or reinduction of the disease suggests that subdominant
epitopes could activate T cells after second challenge with the encephalitogen.
Complete resistance to the reinduction of EAE in rats treated with CFA before
immunization with the encephalitogen could be a consequence of a CFA induced
shift in Th1/Th2 balance towards Th2 response. It was reported that a peptide of
the mycobacterial heat shock protein, HSP65, and the myelin protein 2',32 cyclic
nucleotide 32 phosphodiesterase (CNP) share sequence similarity and exhibit
immunologic cross-reactivity (Birnbaum et et., 1996). Moreover, this hsp-CNP
peptide that itself is non-encephalitogenic protects against EAE and largely
stimulates peptide-specific antibody production (i.e. Th2 response). However,
anti-MBP antibody levels in CFA pretreated rats (CFA/RSC and CFA/GPSC
groups) did not differ from the RSC/RSC group. Taking into account that CFA
contains mycobacterium tuberculosis, and that immune responses to either hsp
or myelin proteins cross-reactive with hsp may influence the development of EAE,
it can be hypothesized that antibodies, other than those specific for MBP, could
be responsible for CFA-induced refractoriness to EAE.
We have found that serum anti-MBP antibody levels were significantly higher
in GPSC immunized rats in comparison with RSC immunized rats three weeks
after induction of EAE. Nevertheless, there was no correlation between antibody
level and clinical score of EAE. Moreover, the production of anti-MBP antibodies
was the lowest in the 5-week-old DA rats that exhibited only moderate sensitivity
to EAE. Our results suggest that anti-MBP antibodies did not have a protective
effect in the induction and reinduction of EAE in DA rats. On the other hand, it was
reported that infusion of MBP primes the immune response such that subsequent
challenge with an encephalitogenic inoculum pushes the response down to a
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non-destructive Th2 autoimmune pathway (Staykova et al., 1997). Determination
of antibody isotype following challenge revealed a change in the ratio of IgG1 to
IgG2a with a significant increase in the amount of IgG1 produced. A higher level
of IgG1, but not total IgG, was found in Wistar rats tolerized by intraperitoneal
infusion of MBP (Rivero et aI., 1997). With respect to the above, it would be
interestingly to test if specific anti-MBP antibodies of IgG1 isotype are negatively
related to the severity of clinical EAE in DA rats.
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INDUKCI,JA I REINDUKCIJA EKSPERIMENTALNOG ALERGIJSKOG ENCEFALOMIJELITISA U
DA PACOVA: UTICAJ STAROSTII ENCEFALITOGENA
DIMITRIJEVIC MIRJANA, LABAN OLGICA, STANOJEVIC STANISLAVA i RADULOVIC JELENA
SADRZAJ
U radu su prikazani rezultati ispitivanja osetljivosti na indukciju i reindukciju
eksperimentalnog alergijskog encefalomojelitisa (EAE) u DA pacova, oba pola,
starosti 5, 8 i 27 nedelja. Za imunizaciju su korisceni homogenati kicmene mozdine .
zamorca (KMZ) iii kicrnene rnozdine Lewis pacova (KMP) u kompletnom
Freund-ovom adjuvansu. Rezultati su pokazali da: a) pol ne utice na razvoj EAE-a
u 5 i 8 nedelja starih DA pacova; b) osetljivost na EAE raste sa staroscu: c) KMP
je jaci encefalitogen od KMZ; d) produkcija anti-mijelin bazni protein (MBP) antitela
je veca nakon imunizacije sa KMZ nego sa KMP; e) nivo anti-MBP antitela nije u
korelaciji sa klinickim znakom EAE-a; f) reindukcija EAE-a je moquca u pacova
starih 27 nedelja ako se za indukciju i/ili reindukciju koristi KMP; i g) anti-MBP
antitela nisu odgovorna za rezistenciju na reindukciju EAE-a u DA pacova.
